Skip to main content
Caplight Logo









Anavasi Diagnostics

Anavasi Diagnostics

Private
Redmond, WashingtonHealthcare & Life Scienceshttps://anavasidx.com

Last Round

Series A

Nov 2, 2022

Total Funding Raised

$23.85M

Company Overview

Anavasi Diagnostics is a medical technology company that develops a clinical diagnostic platform designed for the rapid diagnosis of infectious diseases at the point-of-care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

molecular diagnosticspoint-of-care testingPOCTRT-LAMPrapid diagnostic testmedical device manufacturerinfectious disease testingdiagnostic hardwareclinical diagnosticslab-on-a-chipportable diagnosticsdiagnostic assaytest data managementdecentralized healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anavasi Diagnostics Comparables

Compare Anavasi Diagnostics with similar companies based on industry and business-model similarity.

Anavasi Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AmplifiDx
92%
Novel Microdevices
85%
Kryptos Biotechnologies, Inc.
84%

Anavasi Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 2, 2022
GrantNov 9, 2021
Convertible DebtOct 1, 2021
AngelJan 1, 2021
GrantAug 1, 2020

Anavasi Diagnostics Investors

Notable investors and investment history

Anavasi Diagnostics investors
InvestorRounds
NIH RADxGrant
University of WashingtonGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors increased 53% MoM.

  • Jun 2, 2025

    Monthly visitors increased 67% MoM, reaching 2.5K.

Anavasi Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anavasi Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anavasi Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedmond, Washington
Employee Range9
Year Founded2020
Last FundingNov 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?